187 related articles for article (PubMed ID: 18189193)
1. Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjögren's syndrome.
Ramos HL; Valencia-Pacheco G; Alcocer-Varela J
Scand J Rheumatol; 2008; 37(1):35-9. PubMed ID: 18189193
[TBL] [Abstract][Full Text] [Related]
2. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
5. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
Smith AJ; Gordon TP; Macardle PJ
Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
[TBL] [Abstract][Full Text] [Related]
7. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
[TBL] [Abstract][Full Text] [Related]
8. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
Pertovaara M; Silvennoinen O; Isomäki P
Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
[TBL] [Abstract][Full Text] [Related]
9. SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome.
Hu P; Cai J; Yang C; Xu L; Ma S; Song H; Yang P
Int Immunopharmacol; 2024 Jan; 126():111282. PubMed ID: 38061117
[TBL] [Abstract][Full Text] [Related]
10. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
11. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies.
Willeke P; Gaubitz M; Schotte H; Becker H; Mickholz E; Domschke W; Schlüter B
Rheumatology (Oxford); 2007 Mar; 46(3):479-83. PubMed ID: 16935916
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
[TBL] [Abstract][Full Text] [Related]
14. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
15. CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome.
Zeher M; Surányi P; Szegedi G
Allergol Immunopathol (Madr); 1990; 18(2):75-8. PubMed ID: 1695475
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and functional abnormalities in the peripheral blood T-cells of patients with primary Sjogren's syndrome.
Aziz KE; McCluskey PJ; Wakefield D
Cytometry; 1994 Mar; 18(1):35-41. PubMed ID: 8082485
[TBL] [Abstract][Full Text] [Related]
17. CD5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome.
van de Merwe JP; van den Beemd MW; Hooijkaas H
Neth J Med; 1992 Apr; 40(3-4):158-64. PubMed ID: 1376444
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome.
Amin K; Lúdvíksdóttir D; Janson C; Nettelbladt O; Gudbjörnsson B; Valtysdóttir S; Björnsson E; Roomans GM; Boman G; Sevéus L; Venge P;
Respir Med; 2001 Nov; 95(11):904-10. PubMed ID: 11716205
[TBL] [Abstract][Full Text] [Related]
19. Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association.
Friedman J; Schattner A; Shvidel L; Berrebi A
Semin Arthritis Rheum; 2006 Apr; 35(5):306-11. PubMed ID: 16616153
[TBL] [Abstract][Full Text] [Related]
20. Activation antigens in patients with Sjögren's syndrome.
Zeher M; Pálóczi K; Szegedi G
Haematologia (Budap); 1990; 23(4):193-7. PubMed ID: 2101803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]